View map

Dr. Ajai Chari, MD


New York, NY

About Dr. Ajai Chari

Mount Sinai Oncology will work with patients on a case by case basis to review insurance coverage. Patients can expect a call from the office after booking to discuss these details. The practice will try to accommodate the time selected however the appointment date and time may need to adjusted to better suit the specific patient case. Dr Chari is an Associate Professor of Medicine, the Director of Clinical Research in the Multiple Myeloma Program, and the Associate Director of Clinical Research, Mt Sinai Cancer Clinical Trials Office. Clinical Interests: Plasma cell disorders, including multiple myeloma, AL amyloidosis, POEMS syndrome, plasmacytoma, and monoclonal gammopathies of uncertain significance (MGUS). Dr Chari has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. Research Interests: Dr Chari’s research interests include the development of novel chemotherapy regimens, including phase 1 and 2 studies. He is principal investigator (PI) of several investigator-initiated trials as well as the national and international PI of several industry sponsored studies. As the Director of Clinical Research in the Multiple Myeloma Program, he oversees a program renowned nationally not only for high volume patient accruals but also rigorous quality assurance. The program has played a pivotal role in the approval of each of the 5 most recent drugs to be approved by the FDA for the treatment of multiple myeloma.

In-network insurances

  • 1199SEIU
  • Aetna
  • Aetna Better Health


  • Oncologist

Practice names

Hospital affiliations

  • The Mount Sinai Hospital

Board certifications

  • Hematology (Internal Medicine)

Education and training

  • Medical School - University of California, Los Angeles, Doctor of Medicine
  • Columbia University Medical Center, Residency in Internal Medicine
  • University of California, San Francisco, Fellowship in Hematology and Oncology

Awards and publications

  • Health Care Provider of the Year, Leukemia Lymphoma Society in 2013.
  • Ewig Teaching Award, Deparatment of Medicine, Columbia University College of Physicians and Surgeons in 2008.
  • Phi Beta Kappa, Stanford University in 1994.
  • Chari A, Mazumder A, Jagannath S. Proteasome inhibition and its therapeutic potential in multiple myeloma. Biologics : targets & therapy 2010; 4.
  • Barley K, Harris JA, Diefenbach C, Jagannath S, Chari A. Misdiagnosis of non-hodgkin lymphoma as multiple myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Dec; 30(35).

Languages spoken

  • English

Provider's gender


NPI number


Dr. Ajai Chari's office locations

Mount Sinai Cancer

The Ruttenberg Treatment Center

1470 Madison Ave

New York, NY 10029

Mount Sinai Cancer

10 East 102nd Street, 6th Floor

New York, NY 10029

Patient reviews for Dr. Ajai Chari

All reviews have been submitted by patients after seeing the provider. For more information about Zocdoc's review system, check out this FAQ.
Wait time
Bedside manner
Based on 1 review
Sort by:
Most relevant
Wait time
Bedside manner
Less than 1 year ago
Source: Zocdoc
ZocdocOncologistDr. Ajai Chari, MD